P5

General Information


DRACP ID  DRACP04770

Peptide Name   P5

Sequence  KWKKLLKKPLLKKLLKKL

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Acetylation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C112H204N28O19

Absent amino acids  ACDEFGHIMNQRSTVY

Common amino acids  K

Mass  255045

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  8

Net charge  9

Boman Index  -1318

Hydrophobicity  -61.11

Aliphatic Index  151.67

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  323.53

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21741801

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 21593770

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 18568863

Title  Not available

Doi Not available

Year  Not available

Literature 4

Pubmed ID 18289109

Title  Not available

Doi Not available

Year  Not available

Literature 5

Pubmed ID 16344012

Title  Not available

Doi Not available

Year  Not available

Literature 6

Pubmed ID 14514057

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6494

DRACP is developed by Dr.Zheng's team.